Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Deloitte
Chubb
Farmers Insurance
Baxter
Argus Health
Express Scripts
McKinsey
Fuji
Harvard Business School

Generated: June 20, 2018

DrugPatentWatch Database Preview

Vinblastine sulfate - Generic Drug Details

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

What are the generic sources for vinblastine sulfate and what is the scope of vinblastine sulfate freedom to operate?

Vinblastine sulfate
is the generic ingredient in two branded drugs marketed by Lilly, Abraxis Pharm, Fresenius Kabi Usa, Hospira, and West-ward Pharms Int, and is included in five NDAs. Additional information is available in the individual branded drug profile pages.

There are seven drug master file entries for vinblastine sulfate. One supplier is listed for this compound.
Pharmacology for vinblastine sulfate
Ingredient-typeVinca Alkaloids
Drug ClassVinca Alkaloid
Medical Subject Heading (MeSH) Categories for vinblastine sulfate
Synonyms for vinblastine sulfate
1217677-42-3
143-67-9
29060 LE
AB48729
AC1L68CZ
AI3-52943
AKOS024456494
Ambap143-67-9
AN-15534
AS-12480
Belvan, VLB
BT001134
C11626
C46H58N4O9.H2O4S
C46H58N4O9.H2SO4
C46H60N4O13S
CCRIS 2584
CHEBI:9984
CHEMBL376464
D01068
DR003630
EINECS 205-606-0
EXAL
Exal (TN)
FT-0603354
KDQAABAKXDWYSZ-JKDPCDLQSA-N
l)-5-hydroxy-8-methoxy-6-methyl-3a,3a1,4,5,5a,6,11,12-octahydro-1H-indolizino[8,1-cd]carbazole-5-carboxylate sulfate
LS-162171
methyl (1R,9R,10S,11R,12R,19R)-11-(acetyloxy)-12-ethyl-4-[(13S,15S,17S)-17-ethyl-17-hydroxy-13-(methoxycarbonyl)-1,11-diazatetracyclo[13.3.1.0^{4,12}.0^{5,10}]nonadeca-4(12),5(10),6,8-tetraen-13-yl]-10-hydroxy-5-methoxy-8-met
MFCD00082457
MolPort-006-111-039
MolPort-039-052-360
NSC 49842
NSC-49842
NSC49842
Rozevin sulfate
SCHEMBL3550
Velban
Velban (TN)
Velban (TN) (Lilly)
Vinblastine 5
Vinblastine sulfate (JP17/USP)
Vinblastine sulfate [USAN:JAN]
Vinblastine Sulfate Hydrate
Vinblastine sulphate
Vinblastine, hydrate
Vincaleucoblastine sulfate
VINCALEUKBLASTINE SULFATE
Vincaleukoblastine sulfate
Vincaleukoblastine sulfate (1:1) (salt)
Vincaleukoblastine sulfate salt
Vincaleukoblastine, hydrate
Vincaleukoblastine, monohydrate
Vincaleukoblastine, sulfate
Vincaleukoblastine, sulfate (1:1) (salt)
Vinolastine sulfate
VLB
VLB monosulfate
VLB SULFATE SALT
WLN: T C6 B5665/BS 2AB S BX IN QN NU & & TTTJ FO1 I1 KVO1 KQ LOV1 M2 E-CT F6 D596A EN ON & & TTJ CVO1 Q
WLN: T C6 B5665/BS 2AB S BX IN QN NU & & TTTJ FO1 I1 KVO1 KQ LOV1 M2 E-CT F6D596A EN ON & & TTJ CVO1 Q
Z2241984238

US Patents and Regulatory Information for vinblastine sulfate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
West-ward Pharms Int VINBLASTINE SULFATE vinblastine sulfate INJECTABLE;INJECTION 089395-001 Apr 9, 1987 RX No Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Hospira VINBLASTINE SULFATE vinblastine sulfate INJECTABLE;INJECTION 089565-001 Aug 18, 1987 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Fresenius Kabi Usa VINBLASTINE SULFATE vinblastine sulfate INJECTABLE;INJECTION 089515-001 Apr 29, 1987 RX No Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Abraxis Pharm VINBLASTINE SULFATE vinblastine sulfate INJECTABLE;INJECTION 089011-001 Nov 18, 1985 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fuji
Moodys
Teva
Chinese Patent Office
Healthtrust
Boehringer Ingelheim
Harvard Business School
Cerilliant
Accenture

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.